Molecular mechanism of interleukin-2-induced mucosal homeostasis

American Journal of Physiology - Cell Physiology

Volumn 302, Issue 5, 2012, Pages 735-747

  Mishra, Jayshree ^a   Waters, Christopher M ^b   Kumar, Narendra ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell proliferation; Inflammatory bowel disease; Janus kinase 3; Necrosis

Indexed keywords

DOXYCYCLINE; INTERLEUKIN 2; JANUS KINASE 3; MESSENGER RNA; P52SHCA PROTEIN; PROTEIN; PROTEIN INTERACTING WITH PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; UPREGULATION;

APOPTOSIS; CACO-2 CELLS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HEK293 CELLS; HOMEOSTASIS; HT29 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-2; INTESTINAL MUCOSA; JANUS KINASE 3; RNA, SMALL INTERFERING; SHC SIGNALING ADAPTOR PROTEINS;

EID: 84857837921     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00316.2011     Document Type: Article

References (50)

1. Blais A, Aymard P, Lacour B. Paracellular calcium transport across Caco-2 and HT29 cell monolayers. Pflügers Arch 434: 300-305, 1997.
2. Brunton VG, MacPherson IR, Frame MC. Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim Biophys Acta 1692: 121-144, 2004.
3. Brynskov J, Tvede N, Andersen CB, Vilien M. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 33: 55-58, 1992.
4. Burchill MA, Yang J, Vang KB, Farrar MA. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett 114: 1-8, 2007.
5. Cancelas JA, Jansen M, Williams DA. The role of chemokine activation of Rac GTPases in hematopoietic stem cell marrow homing, retention, and peripheral mobilization. Exp Hematol 34: 976-985, 2006.
6. Ciacci C, Mahida YR, Dignass A, Koizumi M, Podolsky DK. Functional interleukin-2 receptors on intestinal epithelial cells. J Clin Invest 92: 527-532, 1993.
7. Creamer B, Shorter RG, Bamforth J. The turnover and shedding of epithelial cells. I. The turnover in the gastro-intestinal tract. Gut 2: 110-118, 1961.
8. Dahan S, Roth-Walter F, Arnaboldi P, Agarwal S, Mayer L. Epithelia: lymphocyte interactions in the gut. Immunol Rev 215: 243-253, 2007.
9. de Villiers WJ, Varilek GW, de Beer FC, Guo JT, Kindy MS. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine 12: 1337-1347, 2000.
10. Dignass AU, Podolsky DK. Interleukin 2 modulates intestinal epithelial cell function in vitro. Exp Cell Res 225: 422-429, 1996.
11. Ehrhardt RO, Ludviksson BR. When immunization leads to autoimmunity: chronic inflammation as a result of thymic and mucosal dysregulation in IL-2 knock-out mice. Int Rev Immunol 18: 591-612, 1999.
12. Entschladen F, Zanker KS. Locomotion of tumor cells: a molecular comparison to migrating pre-and postmitotic leukocytes. J Cancer Res Clin Oncol 126: 671-681, 2000.
13. Forgue-Lafitte ME, Coudray AM, Breant B, Mester J. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene. Cancer Res 49: 6566-6571, 1989.
14. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68: 545-560, 1992.
15. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999.
16. Hogan PG, Gibson PR, Hapel AJ, Doe WF. Intestinal lymphokineactivated killer cells in inflammatory bowel disease. J Gastroenterol Hepatol 6: 455-460, 1991.
17. Ivanov AI, Parkos CA, Nusrat A. Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 177: 512-524, 2010.
18. Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol 16: 6985-6992, 1996.
19. Karrasch T, Jobin C. Wound healing responses at the gastrointestinal epithelium: a close look at novel regulatory factors and investigative approaches. Z Gastroenterol 47: 1221-1229, 2009.
20. Kmiec Z. Cytokines in inflammatory bowel disease. Arch Immunol Ther Exp (Warsz) 46: 143-155, 1998.
21. Kornbluth A, Present DH, Lichtiger S, Hanauer S. Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol 92: 1424-1428, 1997.
22. Kumar N, Mishra J, Narang VS, Waters CM. Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin. J Biol Chem 282: 30341-30345, 2007.
23. Kusugami K, Matsuura T, West GA, Youngman KR, Rachmilewitz D, Fiocchi C. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology 101: 1594-1605, 1991.
24. Lavagna C, Strup C, Rampal A, Hofman P, Bardon S, Rampal P, Poiree JC. Immunolocalization of a new intestinal antiproliferative factor in human intestinal epithelial cells. Dig Dis Sci 47: 2446-2453, 2002.
25. Li M, Cuff CF, Pestka JJ. T-2 toxin impairment of enteric reovirus clearance in the mouse associated with suppressed immunoglobulin and IFN-gamma responses. Toxicol Appl Pharmacol 217: 76-85, 2006.
26. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841-1845, 1994.
27. Lin JX, Leonard WJ. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev 8: 313-332, 1997.
28. Mahida YR, Gallagher A, Kurlak L, Hawkey CJ. Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol 82: 75-80, 1990.
29. Melgar S, Yeung MM, Bas A, Forsberg G, Suhr O, Oberg A, Hammarstrom S, Danielsson A, Hammarstrom ML. Overexpression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol 134: 127-137, 2003.
30. Mitic LL, Anderson JM. Molecular architecture of tight junctions. Annu Rev Physiol 60: 121-142, 1998.
31. Miura M, Hiwatashi N. Cytokine production in inflammatory bowel disease. J Clin Lab Immunol 18: 81-86, 1985.
32. Murata Y, Yamashita A, Saito T, Sugamura K, Hamuro J. The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice. Int Immunol 14: 627-636, 2002.
33. O'Connor PM, Nieves-Neira W, Kerrigan D, Bertrand R, Goldman J, Kohn KW, Pommier Y. S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cells. Cancer Commun 3: 233-240, 1991.
34. O'Loughlin EV, Pang GP, Noltorp R, Koina C, Batey R, Clancy R. Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes. Gut 49: 636-643, 2001.
35. O'Reilly AM, Pluskey S, Shoelson SE, Neel BG. Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol Cell Biol 20: 299-311, 2000.
36. Parsons JT, Martin KH, Slack JK, Taylor JM, Weed SA. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19: 5606-5613, 2000.
37. Plutzky J, Neel BG, Rosenberg RD. Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 89: 1123-1127, 1992.
38. Podolsky DK. Healing the epithelium: solving the problem from two sides. J Gastroenterol 32: 122-126, 1997.
39. Pullman WE, Doe WF. IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons. Clin Exp Immunol 88: 132-137, 1992.
40. Reinecker HC, Podolsky DK. Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor. Proc Natl Acad Sci USA 92: 8353-8357, 1995.
41. Reynolds AJ, Bartlett SE, Hendry IA. Molecular mechanisms regulating the retrograde axonal transport of neurotrophins. Brain Res Brain Res Rev 33: 169-178, 2000.
42. Rozengurt E. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. J Cell Physiol 177: 507-517, 1998.
43. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261, 1993.
44. Song E, Chen J, Antus B, Wang M, Xie Y, Yao H, Exton MS. Interleukin-2 enhances susceptibility of colon cancer cells to FasR mediated apoptosis by upregulating Fas receptor level and downregulating FAP-1 expression. Int J Immunopathol Pharmacol 13: 113-122, 2000.
45. Stange EF, Modigliani R, Pena AS, Wood AJ, Feutren G, Smith PR. European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group. Gastroenterology 109: 774-782, 1995.
46. Sternthal MB, Murphy SJ, George J, Kornbluth A, Lichtiger S, Present DH. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 103: 937-943, 2008.
47. Stice LL, Vaziri C, Faller DV. Regulation of platelet-derived growth factor signaling by activated p21Ras. Front Biosci 4: D72-86, 1999.
48. Tena JG, Manzano L, Leal JC, Antonio ES, Sualdea V, Alvarez-Mon M. Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4(+) t cells from patients with active Crohn's disease. J Clin Immunol 2006.
49. Wang S, Evers BM. Caco-2 cell differentiation is associated with a decrease in stat protein levels and binding. J Gastrointest Surg 3: 200-207, 1999.
50. Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis 14: 1000-1011, 2008.